Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and ...
After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...
The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for the treatment of ...
A woman in her 60s with a history of atrial fibrillation, hypertension and dyslipidaemia was admitted to the Intensive Care ...